insulin
The partnership includes a patient support programme that brings tailored and age-based educational content to patients with Type 1 diabetes.
The digital tool will be first marketed in Taiwan following regulatory approvals.
Finding a natural pathway to deliver insulin can transform diabetes patients' lives, say Diabetology cofounders Glen Travers and Roger New.
Pharma giant Abbott led the round with participation from Quadrant Capital Advisors Senvest Capital, Janus Henderson, Cormorant Asset Management and other funders.